Home LiteratureArticle Details

PMID: 9481521 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Antiangiogenic drugs as a novel anticancer therapeutic strategy. Which are the more promising agents? What are the clinical developments and indications?

Critical reviews in oncology/hematology ·Vol. 26 ·No. 3 ·1997-12-00 ·Pages 147-62

Gasparini G

Abstract

暂无摘要

MeSH Terms

Antineoplastic Agents/therapeutic use Humans Neoplasms/blood supply,drug therapy Neovascularization, Pathologic/drug therapy

Chemicals

Antineoplastic Agents

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Gasparini G

Division of Oncology, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy. ggaspari@mbox.vol.it

Article Info

Journal

Critical reviews in oncology/hematology

Abbr.

Crit Rev Oncol Hematol

ISSN

1040-8428

DOI

Published

1997-12-00

Pages

147-62

Language

English

Region

Netherlands

NLM ID

8916049

Subset

External Links

Analysis Services